IJMS, Free Full-Text
Por um escritor misterioso
Descrição
To date, non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease, affecting up to 70% of patients with diabetes. Currently, there are no specific drugs available for its treatment. Beyond their anti-hyperglycemic effect and the surprising role of cardio- and nephroprotection, GLP-1 receptor agonists (GLP-1 RAs) have shown a significant impact on body weight and clinical, biochemical and histological markers of fatty liver and fibrosis in patients with NAFLD. Therefore, GLP-1 RAs could be a weapon for the treatment of both diabetes mellitus and NAFLD. The aim of this review is to summarize the evidence currently available on the role of GLP-1 RAs in the treatment of NAFLD and to hypothesize potential future scenarios.
IJMS Free Full-Text Research Advances In Mechanical, 52% OFF
IJMS, Free Full-Text
IJMS, Free Full-Text
IJMS Free Full Text Cell Adhesion And Its Endocytic Regulation InSexiezPicz Web Porn
Ijms Free Full Text Abnormalities In Alternative 25056
IJMS, Free Full-Text
IJMS Free Full-Text Research Advances In Mechanical, 54% OFF
Ijms Free Full Text Recent Advances In Pharmacological 74952
Ijms Free Full Text Preliminary Rna Seq Analysis Of Long Non Coding 55677
de
por adulto (o preço varia de acordo com o tamanho do grupo)